Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 6 | $19,310,880 |
Sells | 45 | $200,596,735 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
22 May 2023 20:36 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | 22 May 2023 | Sale | 1,750,000 | 32.82 | 57,435,000 | D |
22 Sep 2022 16:30 | RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. - GG STRATEGIC | 10% | 20 Sep 2022 | Sale | 267,815 | 41.0201 | 10,985,798 | I |
22 Sep 2022 16:31 | RPRX | Royalty Pharma plc | GIULIANI MARIO GERMANO | Director , 10% | 20 Sep 2022 | Sale | 267,815 | 41.0196 | 10,985,664 | I |
15 Dec 2023 16:31 | RPRX | Royalty Pharma plc | AVARA MANAGEMENT LTD | 10% | 14 Dec 2023 | Sale | 364,441 | 28.9053 | 10,534,276 | I |
15 Dec 2023 16:31 | RPRX | Royalty Pharma plc | AVARA MANAGEMENT LTD | 10% | 13 Dec 2023 | Sale | 307,935 | 28.9542 | 8,916,012 | I |
26 Sep 2022 16:30 | RPRX | Royalty Pharma plc | GIULIANI MARIO GERMANO | Director , 10% | 22 Sep 2022 | Sale | 211,380 | 41.1681 | 8,702,113 | I |
05 Dec 2022 16:44 | RPRX | Royalty Pharma plc | GIULIANI MARIO GERMANO | Director , 10% | 02 Dec 2022 | Sale | 197,766 | 43.9783 | 8,697,412 | I |
05 Dec 2022 16:44 | RPRX | Royalty Pharma plc | GIULIANI MARIO GERMANO | Director , 10% | 01 Dec 2022 | Sale | 165,000 | 44.105 | 7,277,325 | I |
04 Jan 2024 17:16 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | 02 Jan 2024 | Sale | 235,200 | 28.5165 | 6,707,081 | D |
29 Dec 2023 16:29 | RPRX | Royalty Pharma plc | AVARA MANAGEMENT LTD | 10% | 28 Dec 2023 | Sale | 209,863 | 28.2038 | 5,918,934 | I |
04 Jan 2024 17:16 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | 03 Jan 2024 | Sale | 199,098 | 27.7867 | 5,532,276 | D |
17 May 2023 18:41 | RPRX | Royalty Pharma plc | LEGORRETA PABLO G. | CEO, Chairman of the Board, 10% | 16 May 2023 | Purchase | 160,388 | 33.5669 | 5,383,728 | I |
22 Sep 2022 16:31 | RPRX | Royalty Pharma plc | GIULIANI MARIO GERMANO | Director , 10% | 20 Sep 2022 | Sale | 130,330 | 41.0152 | 5,345,511 | I |
22 Sep 2022 16:31 | RPRX | Royalty Pharma plc | GIULIANI MARIO GERMANO | Director , 10% | 21 Sep 2022 | Sale | 125,697 | 41.253 | 5,185,378 | I |
21 Nov 2022 18:12 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | 17 Nov 2022 | Sale | 120,000 | 42.3327 | 5,079,924 | D |
24 May 2023 18:45 | RPRX | Royalty Pharma plc | LEGORRETA PABLO G. | CEO, Chairman of the Board, 10% | 24 May 2023 | Purchase | 150,000 | 32.2496 | 4,837,440 | I |
30 Mar 2023 17:53 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | 30 Mar 2023 | Sale | 130,024 | 36.2575 | 4,714,345 | D |
30 Sep 2022 16:23 | RPRX | Royalty Pharma plc | REDDOCH JAMES F. | EVP & Chief Scientific Officer | 28 Sep 2022 | Sale | 100,000 | 41.2267 | 4,122,670 | I |
28 Jun 2023 16:01 | RPRX | Royalty Pharma plc | LEGORRETA PABLO G. | CEO, Chairman of the Board, 10% | 28 Jun 2023 | Purchase | 130,000 | 29.5136 | 3,836,768 | I |
30 Mar 2023 17:52 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 28 Mar 2023 | Sale | 100,000 | 37.0613 | 3,706,130 | I |
07 Dec 2022 16:30 | RPRX | Royalty Pharma plc | GIULIANI MARIO GERMANO | Director , 10% | 05 Dec 2022 | Sale | 84,302 | 43.148 | 3,637,463 | I |
06 Jun 2023 17:07 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 02 Jun 2023 | Sale | 92,221 | 33.6453 | 3,102,803 | I |
06 Jun 2023 17:07 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 06 Jun 2023 | Sale | 79,099 | 33.8158 | 2,674,796 | I |
17 May 2023 18:41 | RPRX | Royalty Pharma plc | LEGORRETA PABLO G. | CEO, Chairman of the Board, 10% | 17 May 2023 | Purchase | 69,612 | 32.9411 | 2,293,096 | I |
03 Jan 2024 16:31 | RPRX | Royalty Pharma plc | AVARA MANAGEMENT LTD | 10% | 29 Dec 2023 | Sale | 65,803 | 28.0444 | 1,845,406 | I |
13 Dec 2022 18:20 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | 12 Dec 2002 | Sale | 40,010 | 41.9816 | 1,679,684 | D |
13 Jun 2023 16:01 | RPRX | Royalty Pharma plc | LEGORRETA PABLO G. | CEO, Chairman of the Board, 10% | 12 Jun 2023 | Purchase | 45,000 | 32.9988 | 1,484,946 | I |
13 Jun 2023 16:01 | RPRX | Royalty Pharma plc | LEGORRETA PABLO G. | CEO, Chairman of the Board, 10% | 13 Jun 2023 | Purchase | 45,000 | 32.7756 | 1,474,902 | I |
30 Sep 2022 16:15 | RPRX | Royalty Pharma plc | GIULIANI MARIO GERMANO | Director , 10% | 28 Sep 2022 | Sale | 32,593 | 41.05 | 1,337,943 | I |
29 Dec 2023 16:29 | RPRX | Royalty Pharma plc | AVARA MANAGEMENT LTD | 10% | 27 Dec 2023 | Sale | 41,729 | 28.0082 | 1,168,754 | I |
14 Jul 2023 18:09 | RPRX | Royalty Pharma plc | COYNE TERRANCE P. | EVP & CFO | 12 Jul 2023 | Sale | 37,500 | 31.0735 | 1,165,256 | I |
14 Jul 2023 18:09 | RPRX | Royalty Pharma plc | COYNE TERRANCE P. | EVP & CFO | 13 Jul 2023 | Sale | 37,500 | 30.9322 | 1,159,958 | I |
11 Aug 2023 17:00 | RPRX | Royalty Pharma plc | COYNE TERRANCE P. | EVP & CFO | 10 Aug 2023 | Sale | 37,500 | 30.7491 | 1,153,091 | I |
11 Aug 2023 17:00 | RPRX | Royalty Pharma plc | COYNE TERRANCE P. | EVP & CFO | 09 Aug 2023 | Sale | 37,500 | 30.7183 | 1,151,936 | I |
14 Nov 2022 17:13 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 10 Nov 2022 | Sale | 25,000 | 43.853 | 1,096,325 | I |
14 Nov 2022 17:13 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 10 Nov 2022 | Sale | 25,000 | 43.8515 | 1,096,288 | I |
10 Nov 2022 17:04 | RPRX | Royalty Pharma plc | COYNE TERRANCE P. | EVP & CFO | 08 Nov 2022 | Sale | 24,500 | 43.4699 | 1,065,013 | I |
04 Jan 2024 17:16 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | 04 Jan 2024 | Sale | 35,702 | 27.5476 | 983,504 | D |
27 Feb 2023 19:14 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 23 Feb 2023 | Sale | 25,000 | 37.2663 | 931,658 | I |
22 Nov 2022 17:29 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 21 Nov 2022 | Sale | 20,531 | 43.1095 | 885,081 | I |
24 Feb 2023 18:26 | RPRX | Royalty Pharma plc | URIST MARSHALL | EVP, Research & Investments | 22 Feb 2023 | Sale | 23,333 | 37.2965 | 870,239 | D |
13 Dec 2022 18:20 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | 09 Dec 2022 | Sale | 19,990 | 42.068 | 840,939 | D |
06 Jun 2023 17:07 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 05 Jun 2023 | Sale | 19,215 | 33.5387 | 644,446 | I |
22 Nov 2022 17:29 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 22 Nov 2022 | Sale | 14,469 | 43.1874 | 624,878 | I |
30 Mar 2023 17:52 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 29 Mar 2023 | Sale | 12,779 | 37.0268 | 473,165 | I |
30 Mar 2023 17:53 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | 29 Mar 2023 | Sale | 9,926 | 36.95 | 366,766 | D |
19 Dec 2023 16:30 | RPRX | Royalty Pharma plc | AVARA MANAGEMENT LTD | 10% | 15 Dec 2023 | Sale | 10,229 | 28.0085 | 286,499 | I |
04 Nov 2022 19:16 | RPRX | Royalty Pharma plc | COYNE TERRANCE P. | EVP & CFO | 02 Nov 2022 | Sale | 5,500 | 43.0629 | 236,846 | I |
22 Nov 2022 17:29 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 21 Nov 2022 | Sale | 3,100 | 43.109 | 133,638 | I |
22 Nov 2022 17:29 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 22 Nov 2022 | Sale | 1,900 | 43.1416 | 81,969 | I |
06 Jun 2023 17:07 | RPRX | Royalty Pharma plc | LLOYD GEORGE W. | EVP, Investments & CLO | 02 Jun 2023 | Sale | 1,686 | 33.5362 | 56,542 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)